200 related articles for article (PubMed ID: 11419813)
1. Treatment of gastroesophageal reflux disease: to step or not to step.
McGuigan JE
Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
[No Abstract] [Full Text] [Related]
2. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
3. What is the best pharmacologic approach to managing moderate to severe heartburn?
Melton ST; Cimmino A
J Fam Pract; 2001 Oct; 50(10):839. PubMed ID: 11674880
[No Abstract] [Full Text] [Related]
4. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
5. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Bardou M
Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
[No Abstract] [Full Text] [Related]
6. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
7. [When sour does not make merry at all . Fast relief for patients with reflux].
MMW Fortschr Med; 2003 Apr; 145(15):64. PubMed ID: 15104274
[No Abstract] [Full Text] [Related]
8. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
10. Treatment of intermittent reflux symptoms: one size does not fit all.
DeVault KR
J Clin Gastroenterol; 2007 Jul; 41(6):546-7. PubMed ID: 17577109
[No Abstract] [Full Text] [Related]
11. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
12. In support of "step-up therapy" for gastroesophageal reflux disease.
Beck IT
Am J Gastroenterol; 2002 Feb; 97(2):503-4. PubMed ID: 11866309
[No Abstract] [Full Text] [Related]
13. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
Scarpignato C
Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
[No Abstract] [Full Text] [Related]
14. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
15. PPIs vs H2RAs for erosive reflux esophagitis.
King VJ
J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
[No Abstract] [Full Text] [Related]
16. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
Morreale A
Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
[No Abstract] [Full Text] [Related]
17. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
Gregor JC
Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
[No Abstract] [Full Text] [Related]
18. [Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
Habu Y; Fukui Y; Maruno T; Hisatsune H; Kawai K
Nihon Rinsho; 2007 May; 65(5):951-5. PubMed ID: 17511239
[TBL] [Abstract][Full Text] [Related]
19. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Yoshino T; Shio S; Hayakumo T; Kawai K
Nihon Rinsho; 2004 Aug; 62(8):1504-9. PubMed ID: 15344541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
